PAVmed Company Leadership
| PAVM Stock | USD 10.45 0.17 1.65% |
PAVmed employs about 39 people. The company is managed by 11 executives with a total tenure of roughly 91 years, averaging almost 8.0 years of service per executive, having 3.55 employees per reported executive. Analysis of PAVmed's management performance can provide insight into the firm performance.
PAVmed Management Team Effectiveness
The company has return on total asset (ROA) of (0.3678) % which means that it has lost $0.3678 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1744 %, meaning that it created $0.1744 on every $100 dollars invested by stockholders. PAVmed's management efficiency ratios could be used to measure how well PAVmed manages its routine affairs as well as how well it operates its assets and liabilities.PAVmed Inc holds 17.61 pct. of its outstanding shares held by insiders and 9.7 pct. owned by third-party entities.
Some institutional investors establish a significant position in stocks such as PAVmed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of PAVmed, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
PAVmed Workforce Comparison
PAVmed Inc is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,208. PAVmed holds roughly 39.0 in number of employees claiming about 3% of equities under Health Care industry.
The company has Profit Margin (PM) of 106.72 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (968.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $968.8. PAVmed Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PAVmed insiders, such as employees or executives, is commonly permitted as long as it does not rely on PAVmed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, PAVmed insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aklog Lishan over a week ago Acquisition by Aklog Lishan of 150000 shares of PAVmed subject to Rule 16b-3 | ||
O'neil Shaun over three months ago Acquisition by Oneil Shaun of 150000 shares of PAVmed subject to Rule 16b-3 | ||
Aklog Lishan over six months ago Disposition of 980 shares by Aklog Lishan of PAVmed at 1.15 subject to Rule 16b-3 | ||
Sirovich Matthew over six months ago Disposition of 53036 shares by Sirovich Matthew of PAVmed at 1.9963 subject to Rule 16b-3 | ||
Glennon Michael J over six months ago Acquisition by Glennon Michael J of 80000 shares of PAVmed at 1.59 subject to Rule 16b-3 | ||
Tasso Partners, Llc over six months ago Insider Trading | ||
Deguzman Brian J. over six months ago Acquisition by Deguzman Brian J. of 50000 shares of PAVmed at 1.59 subject to Rule 16b-3 | ||
Aklog Lishan over a year ago Disposition of 12450 shares by Aklog Lishan of PAVmed at 1.6 subject to Rule 16b-3 |
PAVmed Notable Stakeholders
A PAVmed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PAVmed often face trade-offs trying to please all of them. PAVmed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PAVmed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dennis CPA | CFO President | Profile | |
| Shaun MBA | Executive COO | Profile | |
| Michael Gordon | General VP | Profile | |
| Deepika Lakhani | Chief VP | Profile | |
| Lishan MD | Chairman CEO | Profile | |
| Michael Parks | Vice Relations | Profile | |
| Adrian Miller | VP Relations | Profile | |
| Matthew Riley | Senior Relations | Profile | |
| Brian MD | Chief Affairs | Profile | |
| Victoria Lee | Senior Officer | Profile | |
| Victoria MD | Senior Officer | Profile |
About PAVmed Management Performance
The success or failure of an entity such as PAVmed Inc often depends on how effective the management is. PAVmed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PAVmed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PAVmed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PAVmed Inc. operates as a medical device company in the United States. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Pavmed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
PAVmed Workforce Analysis
Traditionally, organizations such as PAVmed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PAVmed within its industry.PAVmed Manpower Efficiency
Return on PAVmed Manpower
| Revenue Per Employee | 76.8K | |
| Revenue Per Executive | 272.3K | |
| Net Income Per Employee | 728.9K | |
| Net Income Per Executive | 2.6M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.